Pharmacological studies of platelet-activating factor (PAF)-induced augmentation of response to histamine in guinea-pigs
References (19)
- et al.
The platelet in asthma
Lancet
(1984) - et al.
Dependency of the PAF-acether induced bronchospasm on the lipoxygenase pathway in guinea pigs
Prostaglandins
(1983) - et al.
Effect of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man
Lancet
(1986) - et al.
The effect of the selective PAF antagonist BW52021 on PAF- and antigen-induced bronchial hyperreactivity and eosinophil accumulation
Eur J Pharmacol
(1988) - et al.
Pharmacological profile of AA-861, 5-lipoxygenase inhibitor
Prostaglandins
(1983) New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma
J Allergy Clin Immunol
(1989)Asthma and inflammation
J Allergy Clin Immunol
(1991)Late-phase asthmatic responses and airway inflammation
J Allergy Clin Immunol
(1989)- et al.
The eosinophils and the pathophysiology of asthma
J Allergy Clin Immunol
(1986)
There are more references available in the full text version of this article.
Cited by (14)
Prostanoids as pharmacological targets in COPD and asthma
2006, European Journal of PharmacologyEffect of combined leukotriene D<inf>4</inf> and thromboxane A<inf>2</inf> receptor antagonist on mediator-controlled resistance in guinea pigs
2000, European Journal of PharmacologySensitization of the histamine H<inf>1</inf> receptor by increased ligand affinity
1998, Journal of Biological ChemistryFrom the design to the clinical application of thromboxane modulators
2006, Current Pharmaceutical DesignEicosanoids as therapeutic targets in asthma
2006, Letters in Drug Design and Discovery
Copyright © 1994 Published by Elsevier Ltd.